|
[1]
|
刘宗超, 李哲轩, 张阳, 等. 2020全球癌症统计报告解读[J]. 肿瘤综合治疗电子杂志, 2021, 7(2): 1-13.
|
|
[2]
|
Noone, A.M., Howlader, N., Krapcho, M., Miller, D., Brest, A., Yu, M., et al. (2018) SEER Cancer Statistics Review, 1975-2015. National Cancer Institute.
https://seer.cancer.gov/csr/1975_2015/
|
|
[3]
|
Yang, C., Kim, H.S., Song, G. and Lim, W. (2019) The Potential Role of Exosomes Derived from Ovarian Cancer Cells for Diagnostic and Therapeutic Approaches. Journal of Cellular Physiology, 234, 21493-21503. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Elattar, A., Bryant, A., Winter-Roach, B.A., Hatem, M. and Naik, R. (2011) Optimal Primary Surgical Treatment for Advanced Epithelial Ovarian Cancer. Cochrane Database of Systematic Reviews, No. 8, CD007565. [Google Scholar] [CrossRef]
|
|
[5]
|
Kobayashi, H., Yamada, Y., Sado, T., Sakata, M., Yoshida, S., Kawaguchi, R., et al. (2008) A Randomized Study of Screening for Ovarian Cancer: A Multicenter Study in Japan. International Journal of Gynecological Cancer, 18, 414-420. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Menon, U., Gentry-Maharaj, A., Hallett, R., Ryan, A., Burnell, M., Sharma, A., et al. (2009) Sensitivity and Specificity of Multimodal and Ultrasound Screening for Ovarian Cancer, and Stage Distribution of Detected Cancers: Results of the Prevalence Screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS). The Lancet Oncology, 10, 327-340. [Google Scholar] [CrossRef]
|
|
[7]
|
Prorok, P.C., Andriole, G.L., Bresalier, R.S., Buys, S.S., Chia, D., David Crawford, E., et al. (2000) Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. Controlled Clinical Trials, 21, 273S-309S. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Buys, S.S. (2011) Effect of Screening on Ovarian Cancer Mortality: The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Randomized Controlled Trial. JAMA, 305, 2295-2303. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Mol, B.W.J., Bayram, N., Lijmer, J.G., Wiegerinck, M.A.H.M., Bongers, M.Y., van der Veen, F., et al. (1998) The Performance of CA-125 Measurement in the Detection of Endometriosis: A Meta-Analysis. Fertility and Sterility, 70, 1101-1108. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Topalak, O., Saygili, U., Soyturk, M., Karaca, N., Batur, Y., Uslu, T., et al. (2002) Serum, Pleural Effusion, and Ascites CA-125 Levels in Ovarian Cancer and Nonovarian Benign and Malignant Diseases: A Comparative Study. Gynecologic Oncology, 85, 108-113. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Shah, C.A., Lowe, K.A., Paley, P., Wallace, E., Anderson, G.L., McIntosh, M.W., et al. (2009) Influence of Ovarian Cancer Risk Status on the Diagnostic Performance of the Serum Biomarkers Mesothelin, HE4, and CA125. Cancer Epidemiology, Biomarkers & Prevention, 18, 1365-1372. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Moore, R.G., Miller, M.C., Eklund, E.E., Lu, K.H., Bast, R.C. and Lambert-Messerlian, G. (2012) Serum Levels of the Ovarian Cancer Biomarker HE4 Are Decreased in Pregnancy and Increase with Age. American Journal of Obstetrics and Gynecology, 206, 349.e1-349.e7. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Chang, X., Ye, X., Dong, L., Cheng, H., Cheng, Y., Zhu, L., et al. (2011) Human Epididymis Protein 4 (HE4) as a Serum Tumor Biomarker in Patients with Ovarian Carcinoma. International Journal of Gynecological Cancer, 21, 852-858. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Tian, Y., Wang, C., Cheng, L., Zhang, A., Liu, W., Guo, L., et al. (2015) Determination of Reference Intervals of Serum Levels of Human Epididymis Protein 4 (HE4) in Chinese Women. Journal of Ovarian Research, 8, Article No. 72. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Boukouris, S. and Mathivanan, S. (2015) Exosomes in Bodily Fluids Are a Highly Stable Resource of Disease Biomarkers. PROTEOMICS—Clinical Applications, 9, 358-367. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Salvador, S., Scott, S., Glanc, P., Eiriksson, L., Jang, J., Sebastianelli, A., et al. (2020) Guideline No. 403: Initial Investigation and Management of Adnexal Masses. Journal of Obstetrics and Gynaecology Canada, 42, 1021-1029.e3. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Mathieu, K.B., Bedi, D.G., Thrower, S.L., Qayyum, A. and Bast, R.C. (2018) Screening for Ovarian Cancer: Imaging Challenges and Opportunities for Improvement. Ultrasound in Obstetrics & Gynecology, 51, 293-303. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Pan, B. and Johnstone, R.M. (1983) Fate of the Transferrin Receptor during Maturation of Sheep Reticulocytes in vitro: Selective Externalization of the Receptor. Cell, 33, 967-978. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
van Niel, G., D’Angelo, G. and Raposo, G. (2018) Shedding Light on the Cell Biology of Extracellular Vesicles. Nature Reviews Molecular Cell Biology, 19, 213-228. [Google Scholar] [CrossRef] [PubMed]
|
|
[20]
|
Zhang, H. and Grizzle, W.E. (2014) Exosomes: A Novel Pathway of Local and Distant Intercellular Communication That Facilitates the Growth and Metastasis of Neoplastic Lesions. The American Journal of Pathology, 184, 28-41. [Google Scholar] [CrossRef] [PubMed]
|
|
[21]
|
Beach, A., Zhang, H., Ratajczak, M.Z. and Kakar, S.S. (2014) Exosomes: An Overview of Biogenesis, Composition and Role in Ovarian Cancer. Journal of Ovarian Research, 7, Article No. 14. [Google Scholar] [CrossRef] [PubMed]
|
|
[22]
|
Cocucci, E., Racchetti, G. and Meldolesi, J. (2009) Shedding Microvesicles: Artefacts No More. Trends in Cell Biology, 19, 43-51. [Google Scholar] [CrossRef] [PubMed]
|
|
[23]
|
兰霄霄, 周志阳, 徐欣欣, 等. 细胞外囊泡及其在卵巢癌诊治中的研究进展[J]. 温州医科大学学报, 2017, 47(12): 931-936.
|
|
[24]
|
Van Doormaal, F.F., Kleinjan, A., Di Nisio, M., et al. (2009) Cell-Derived Microvesicles and Cancer. The Netherlands Journal of Medicine, 67, 266-273.
|
|
[25]
|
Johnstone, R.M., Adam, M., Hammond, J.R., Orr, L. and Turbide, C. (1987) Vesicle Formation during Reticulocyte Maturation. Association of Plasma Membrane Activities with Released Vesicles (Exosomes). Journal of Biological Chemistry, 262, 9412-9420. [Google Scholar] [CrossRef] [PubMed]
|
|
[26]
|
Keller, S., Sanderson, M.P., Stoeck, A. and Altevogt, P. (2006) Exosomes: From Biogenesis and Secretion to Biological Function. Immunology Letters, 107, 102-108. [Google Scholar] [CrossRef] [PubMed]
|
|
[27]
|
Kowal, J., Tkach, M. and Théry, C. (2014) Biogenesis and Secretion of Exosomes. Current Opinion in Cell Biology, 29, 116-125. [Google Scholar] [CrossRef] [PubMed]
|
|
[28]
|
Colombo, M., Raposo, G. and Théry, C. (2014) Biogenesis, Secretion, and Intercellular Interactions of Exosomes and Other Extracellular Vesicles. Annual Review of Cell and Developmental Biology, 30, 255-289. [Google Scholar] [CrossRef] [PubMed]
|
|
[29]
|
Melo, S.A., Sugimoto, H., O’Connell, J.T., Kato, N., Villanueva, A., Vidal, A., et al. (2014) Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis. Cancer Cell, 26, 707-721. [Google Scholar] [CrossRef] [PubMed]
|
|
[30]
|
Fong, M.Y., Zhou, W., Liu, L., Alontaga, A.Y., Chandra, M., Ashby, J., et al. (2015) Breast-Cancer-Secreted miR-122 Reprograms Glucose Metabolism in Premetastatic Niche to Promote Metastasis. Nature Cell Biology, 17, 183-194. [Google Scholar] [CrossRef] [PubMed]
|
|
[31]
|
Li, W., Li, C., Zhou, T., Liu, X., Liu, X., Li, X., et al. (2017) Role of Exosomal Proteins in Cancer Diagnosis. Molecular Cancer, 16, Article No. 145. [Google Scholar] [CrossRef] [PubMed]
|
|
[32]
|
Chevillet, J.R., Kang, Q., Ruf, I.K., Briggs, H.A., Vojtech, L.N., Hughes, S.M., et al. (2014) Quantitative and Stoichiometric Analysis of the MicroRNA Content of Exosomes. Proceedings of the National Academy of Sciences, 111, 14888-14893. [Google Scholar] [CrossRef] [PubMed]
|
|
[33]
|
Escrevente, C., Keller, S., Altevogt, P. and Costa, J. (2011) Interaction and Uptake of Exosomes by Ovarian Cancer Cells. BMC Cancer, 11, Article No. 108. [Google Scholar] [CrossRef] [PubMed]
|
|
[34]
|
Gray, H.J. and Garcia, R.L. (2019) Cancer of the Ovary, Fallopian Tube, and Peritoneum: Staging and Surgical Management. UpToDate.
|
|
[35]
|
Zhang, W., Ou, X. and Wu, X. (2019) Proteomics Profiling of Plasma Exosomes in Epithelial Ovarian Cancer: A Potential Role in the Coagulation Cascade, Diagnosis and Prognosis. International Journal of Oncology, 54, 1719-1733. [Google Scholar] [CrossRef] [PubMed]
|
|
[36]
|
Cho, M.S., Vasquez, H.G., Rupaimoole, R., Pradeep, S., Wu, S., Zand, B., et al. (2014) Autocrine Effects of Tumor-Derived Complement. Cell Reports, 6, 1085-1095. [Google Scholar] [CrossRef] [PubMed]
|
|
[37]
|
Nunez-Cruz, S., Gimotty, P.A., Guerra, M.W., Connolly, D.C., Wu, Y., DeAngelis, R.A., et al. (2012) Genetic and Pharmacologic Inhibition of Complement Impairs Endothelial Cell Function and Ablates Ovarian Cancer Neovascularization. Neoplasia, 14, 994-1004. [Google Scholar] [CrossRef] [PubMed]
|
|
[38]
|
Larsen, A.K., Escargueil, A.E. and Skladanowski, A. (2000) Resistance Mechanisms Associated with Altered Intracellular Distribution of Anticancer Agents. Pharmacology & Therapeutics, 85, 217-229. [Google Scholar] [CrossRef] [PubMed]
|
|
[39]
|
Warren, L., Jardillier, J.C. and Ordentlich, P. (1991) Secretion of Lysosomal Enzymes by Drug-Sensitive and Multiple Drug-Resistant Cells. Cancer Research, 51, 1996-2001.
|
|
[40]
|
Weiner‐Gorzel, K., Dempsey, E., Milewska, M., McGoldrick, A., Toh, V., Walsh, A., et al. (2015) Overexpression of the MicroRNA miR‐433 Promotes Resistance to Paclitaxel through the Induction of Cellular Senescence in Ovarian Cancer Cells. Cancer Medicine, 4, 745-758. [Google Scholar] [CrossRef] [PubMed]
|
|
[41]
|
Yin, J., Yan, X., Yao, X., Zhang, Y., Shan, Y., Mao, N., et al. (2012) Secretion of Annexin A3 from Ovarian Cancer Cells and Its Association with Platinum Resistance in Ovarian Cancer Patients. Journal of Cellular and Molecular Medicine, 16, 337-348. [Google Scholar] [CrossRef] [PubMed]
|
|
[42]
|
Dorayappan, K.D.P., Wanner, R., Wallbillich, J.J., Saini, U., Zingarelli, R., Suarez, A.A., et al. (2018) Hypoxia-Induced Exosomes Contribute to a More Aggressive and Chemoresistant Ovarian Cancer Phenotype: A Novel Mechanism Linking STAT3/Rab Proteins. Oncogene, 37, 3806-3821. [Google Scholar] [CrossRef] [PubMed]
|
|
[43]
|
Arend, R., Westin, S.N. and Coleman, R.L. (2020) Decision Analysis for Secondline Maintenance Treatment of Platinum Sensitive Recurrent Ovarian Cancer: A Review. International Journal of Gynecological Cancer, 30, 684-694. [Google Scholar] [CrossRef] [PubMed]
|
|
[44]
|
Rojas, V., Hirshfield, K., Ganesan, S. and Rodriguez-Rodriguez, L. (2016) Molecular Characterization of Epithelial Ovarian Cancer: Implications for Diagnosis and Treatment. International Journal of Molecular Sciences, 17, Article 2113. [Google Scholar] [CrossRef] [PubMed]
|
|
[45]
|
Zhang, Y., Shi, J. and Li, C. (2019) Small Extracellular Vesicle Loading Systems in Cancer Therapy: Current Status and the Way Forward. Cytotherapy, 21, 1122-1136. [Google Scholar] [CrossRef] [PubMed]
|
|
[46]
|
Kooijmans, S.A.A., Vader, P., van Dommelen, S.M., van Solinge, W.W. and Schiffelers, R.M. (2012) Exosome Mimetics: A Novel Class of Drug Delivery Systems. International Journal of Nanomedicine, 7, 1525-1541. [Google Scholar] [CrossRef] [PubMed]
|
|
[47]
|
Zhang, X., Chen, J., Kang, Y., Hong, S., Zheng, Y., Sun, H., et al. (2013) Targeted Paclitaxel Nanoparticles Modified with Follicle-Stimulating Hormone Β 81-95 Peptide Show Effective Antitumor Activity against Ovarian Carcinoma. International Journal of Pharmaceutics, 453, 498-505. [Google Scholar] [CrossRef] [PubMed]
|
|
[48]
|
Yue, Y., Li, J., Zhou, X., et al. (2017) Preparation of FSHβ Anchored Exosomes and Its Effect on Induced Killing of Ovarian Cancer Cell. Chinese Journal of Woman and Child Health Research, 28, 1601-1605.
|
|
[49]
|
Wang, W., Wu, L., Li, C., Zhou, X., Liu, P., Jia, X., et al. (2019) Five Serum MicroRNAs for Detection and Predicting of Ovarian Cancer. European Journal of Obstetrics & Gynecology and Reproductive Biology: X, 3, Article 100017. [Google Scholar] [CrossRef] [PubMed]
|
|
[50]
|
Bagnoli, M., Canevari, S., Califano, D., Losito, S., Maio, M.D., Raspagliesi, F., et al. (2016) Development and Validation of a MicroRNA-Based Signature (MiROvaR) to Predict Early Relapse or Progression of Epithelial Ovarian Cancer: A Cohort Study. The Lancet Oncology, 17, 1137-1146. [Google Scholar] [CrossRef] [PubMed]
|
|
[51]
|
Ditto, A., De Cecco, L., Paolini, B., Alberti, P., Martinelli, F., Leone Roberti Maggiore, U., et al. (2022) Validation of MiROvaR, a MicroRNA-Based Predictor of Early Relapse in Early Stage Epithelial Ovarian Cancer as a New Strategy to Optimise Patients’ Prognostic Assessment. European Journal of Cancer, 161, 55-63. [Google Scholar] [CrossRef] [PubMed]
|
|
[52]
|
Günel, T., Gumusoglu, E., Dogan, B., Ertem, F.B., Hosseini, M.K., Cevik, N., et al. (2018) Potential Biomarker of Circulating HSA-miR-1273g-3p Level for Detection of Recurrent Epithelial Ovarian Cancer. Archives of Gynecology and Obstetrics, 298, 1173-1180. [Google Scholar] [CrossRef] [PubMed]
|
|
[53]
|
Alharbi, M., Sharma, S., Guanzon, D., Lai, A., Zuñiga, F., Shiddiky, M.J.A., et al. (2020) Mirna Signature in Small Extracellular Vesicles and Their Association with Platinum Resistance and Cancer Recurrence in Ovarian Cancer. Nanomedicine: Nanotechnology, Biology and Medicine, 28, Article 102207. [Google Scholar] [CrossRef] [PubMed]
|
|
[54]
|
Meng, X., Müller, V., Milde-Langosch, K., Trillsch, F., Pantel, K. and Schwarzenbach, H. (2016) Diagnostic and Prognostic Relevance of Circulating Exosomal miR-373, miR-200a, miR-200b and miR-200c in Patients with Epithelial Ovarian Cancer. Oncotarget, 7, 16923-16935. [Google Scholar] [CrossRef] [PubMed]
|
|
[55]
|
Amaria, R., Knisely, A., Vining, D., Kopetz, S., Overman, M.J., Javle, M., et al. (2024) Efficacy and Safety of Autologous Tumor-Infiltrating Lymphocytes in Recurrent or Refractory Ovarian Cancer, Colorectal Cancer, and Pancreatic Ductal Adenocarcinoma. Journal for ImmunoTherapy of Cancer, 12, e006822. [Google Scholar] [CrossRef] [PubMed]
|
|
[56]
|
Vaksman, O., Tropé, C., Davidson, B. and Reich, R. (2014) Exosome-Derived miRNAs and Ovarian Carcinoma Progression. Carcinogenesis, 35, 2113-2120. [Google Scholar] [CrossRef] [PubMed]
|
|
[57]
|
Cai, J., Gong, L., Li, G., Guo, J., Yi, X. and Wang, Z. (2021) Exosomes in Ovarian Cancer Ascites Promote Epithelial-Mesenchymal Transition of Ovarian Cancer Cells by Delivery of miR-6780b-5p. Cell Death & Disease, 12, Article No. 210. [Google Scholar] [CrossRef] [PubMed]
|